700 likes | 837 Views
LUNG TRANSPLANTATION. Overall. 1537. 1508. 1417. 1413. 1410. 1342. 1337. 1206. 1069. 902. 685. 408. 185. 80. 15. 47. 13. NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND PROCEDURE TYPE. NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND LOCATION.
E N D
LUNG TRANSPLANTATION Overall
1537 1508 1417 1413 1410 1342 1337 1206 1069 902 685 408 185 80 15 47 13 NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND PROCEDURE TYPE
AVERAGE CENTER VOLUMELung Transplants: January 1, 1998 - June 30,2002
AGE DISTRIBUTION OF LUNG TRANSPLANT RECIPIENTS(1/1985-6/2002)
1985-1996 1/1997-6/2002 AGE DISTRIBUTION OF LUNG TRANSPLANT RECIPIENTS BY ERA
LUNG TRANSPLANTATIONActuarial Survival (Transplants: January 1990 - June 2001)
LUNG TRANSPLANTATION Adult Recipients
ADULT LUNG TRANSPLANTATION: Indications(Transplants: January 1995 - June 2002) Single Lung Transplants Bilateral/Double Lung Transplants
ADULT LUNG TRANSPLANTATIONActuarial Survival by Era (Transplants: January 1988 – June 2001) Survival comparisons by era 1988-1992 vs. 1993-1997: p = 0.008 1988-1992 vs. 1998-2001: p < 0.0001 1993-1997 vs. 1998-2001: p = 0.3
ADULT LUNG TRANSPLANTATIONActuarial Survival by Age Group(Transplants: January 1990 – June 2001)
ADULT LUNG TRANSPLANTATIONActuarial Survival By Diagnosis(Transplants: January 1990 – June 2001)
ADULT LUNG TRANSPLANTATIONActuarial Survival By Diagnosis Conditional on Survival to 3 Months(Transplants: January 1990 – June 2001)
ADULT LUNG TRANSPLANTATIONActuarial Survival By Diagnosis Conditional on Survival to 1 Year(Transplants: January 1990 – June 2001)
ADULT LUNG TRANSPLANTATIONActuarial Survival for Congenital Diagnosis(Transplants: January 1990 – June 2001)
ADULT LUNG TRANSPLANTATIONActuarial Survival By Procedure Type (Transplants: January 1990 – June 2001)Diagnosis: Alpha-1 Antitrypsin Deficiency P = 0.008
ADULT LUNG TRANSPLANTATIONActuarial Survival by Procedure Type (Transplants: January 1990 – June 2001) Diagnosis: Emphysema/COPD P < 0.0001
ADULT LUNG TRANSPLANTATIONActuarial Survival by Procedure Type (Transplants: January 1990 – June 2001)Diagnosis: IPF P = 0.2
ADULT LUNG TRANSPLANTATIONActuarial Survival by Procedure Type (Transplants: January 1990 – June 2001)Diagnosis: PPH P = 0.3
ADULT LUNG TRANSPLANTS (1995-6/2001)Risk Factors for 1 Year Mortality (N=7,262)
ADULT LUNG TRANSPLANTS (1995-6/2001)Risk Factors for 1 Year Mortality (N=7,262)
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year Mortality
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityRecipient Age
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityDonor Age
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityBMI Ratio = Donor BMI/Recipient BMI
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityCenter volume
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityIschemia time
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityCreatinine
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityOxygen required at rest
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityPredicted FeV1% for IPF patients
ADULT LUNG TRANSPLANTS(1/1995-6/2001)Risk Factors for 1 Year MortalityBilirubin
ADULT LUNG TRANSPLANTS (1995-6/2001)Factors Not Significant for 1 Year Mortality Recipient factors: Hospitalized, pCO2, gender, chronic steroid use, transfusions, history of malignancy, recent infection requiring IV drug therapy Donor factors: Gender, clinical infection, history of hypertension, history of cancer, COD Transplant factors: Procedure type, ABO compatibility, HLA mismatch, year of transplant
ADULT LUNG TRANSPLANTS (1995-6/1997)Risk Factors for 5 Year Mortality (N=2,771)
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year Mortality
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year MortalityRecipient Age
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year MortalityDonor Age
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year MortalityBilirubin
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year MortalityPA Systolic
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year MortalitypCO2
ADULT LUNG TRANSPLANTS (1995-6/1997)Factors Not Significant for 5 Year Mortality Recipient factors: Ventilator, inotropes, hospitalized, chronic steroid use, transfusions, history of malignancy, PRA, gender, FeV1, FVC, repeat transplant Donor factors: Gender, clinical infection, history of hypertension, history of cancer, history of diabetes, COD Transplant factors: Procedure type, ABO compatibility, HLA mismatch
ADULT LUNG TRANSPLANTS (1995-6/1997)Risk Factors for 5 Year MortalityConditional on Survival to 1 Year (N=1,899)
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year MortalityConditional on Survival to 1 Year
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year Mortality Condtional on Survival to 1 YearRecipient Age
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year Mortality Conditional on Survival to 1 YearDonor Age
ADULT LUNG TRANSPLANTS(1/1995-6/1997)Risk Factors for 5 Year Mortality Conditional on Survival to 1 YearRecipient Height
ADULT LUNG TRANSPLANTS (1995-6/1997)Factors Not Significant for Conditional 5 Year Mortality Recipient factors: Diagnosis, ventilator, inotropes, hospitalized, pCO2, gender, chronic steroid use, transfusions, history of malignancy, PRA, repeat transplant, FeV1, FVC Donor factors: Gender, clinical infection, history of hypertension, history of cancer, history of diabetes, COD Transplant factors: ABO compatibility, HLA mismatch, CMV mismatch
ADULT LUNG TRANSPLANTS (1995-6/1997)Factors Not Significant for Conditional 5 Year Mortality Post-transplant factors: Treated for rejection, stroke, dialysis, prolonged graft dysfunction, bronchopleural fistula, airway dehiscence